Michigan University granted 173 licenses and options last year and spun out 12 new businesses.
Michigan University yesterday revealed it achieved a personal best during the fiscal year ending June 30 with 173 license and option agreements signed, including 12 new spinouts generated.
Michigan also registered 135 patents. Revenues from licensed research came in at $23m, which was reinvested in future research.
Faculty disclosed 428 new inventions in the fiscal year, a slight increase of 422 compared to the previous period. It marks the fourth consecutive year of more than 400 inventions.
Among the spinouts, established through the university’s commercialisation arm Tech Transfer Venture Center, was ViewPoint Therapeutics, which secured $4m in series A capital in May 2016 and is working on therapies for eye diseases.
Ken Nisbet, associate vice-president for research-technology transfer, said: “It is gratifying to see this record-setting number for our most important metric in tech transfer performance. It reflects the deployment of Michigan inventions into the marketplace where they can have positive benefits for the general public.”
